Trial Profile
An Open-Label, Randomized, Crossover Study to Assess the Bioavailability of Dexpramipexole Administered in Soft Food and Water, and in Intact Tablet Form in the Fasted and Fed States in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Dexpramipexole (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Pharmacokinetics
- Sponsors Knopp Biosciences
- 16 Aug 2012 Actual initiation date (Jun 2012) added as reported by ClinicalTrials.gov.
- 16 Aug 2012 Actual end date (July 2012) added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.